Blockbuster drug, it’s been a long road. You’ve given me all I’ve ever needed… global dominance for more than 10 years, exponential growth, accolades beyond belief.
Blockbuster drug, I love you more than my kids. But you had to break my heart. You had to start to die and when that clock strikes 12 on December 31, you will no longer be mine.
Blockbuster drug, I wasn’t ready for this. You have been on life support for a while now. And I saw all of the signs.
But who can say no to a sure thing? I knew I had to plan for your departure. I tried to lobby for a patent extension. I was promised another just like you, when your time came up. And everyone around here kept saying when you were gone, we’d continue like nothing happened.
What about a reformulation, someone said? An extended release version would surely get you a new patent. And even though marrying you off with a complete stranger seemed asinine at the time, at least it would have kept you around a little longer.
Sadly, a dose of reality has slowly started to come into focus. There was no patent extension, despite millions spent on lobbying. The pipeline has proved not very rich. And approval of the successor drug was held up for more than a year with severe manufacturing problems.
I guess I could take the easy route and share you, but I’m not into open relationships. Next time, I won’t be so close-minded about the future, if there is a next time.
What are biologics, anyway?
Blockbuster drug, it’s time to say goodbye. When you cross over to the other side, remember me, because no one else will.
– VP of Marketing
pharmageddon2012.wordpress.com 